The Kable Newsletter Sponsorship: Audience, Reach & Sponsor Fit
Daily capsule of essential life sciences news
Overview
The Kable Newsletter Sponsorship: Audience, Reach & Sponsor Fit Daily capsule of essential life sciences news
Key facts
| Accepts sponsors | Yes |
|---|---|
| Frequency | Weekly |
| Top audience geography | United States, India, Belgium |
| Cross-promotion | May be available |
About this newsletter
The Kable is a curated Monday to Friday newsletter for C-suite executives in or on the periphery of the pharma, biotech and healthcare industries.
You get one daily email with concise summaries of industry and mainstream articles, blogs and social feeds straight to your inbox.
We filter out the noise to bring you business intelligence you can use.
Audience breakdown
- United States — 5
- India — 2
- Belgium — 1
- China — 1
- United Kingdom — 1
FAQ
- Does The Kable accept newsletter sponsors?
- Yes — our directory listing shows The Kable accepts sponsored placements. Confirm current rates and availability on the publisher’s site before you pitch.
- Who is the The Kable audience?
- The Kable covers Life Sciences, Pharma, Healthcare, Technology. Readers skew toward life sciences readers, founders and operators in that niche. Geography signals point to readers in United States, India, Belgium, China, United Kingdom. Reach signal from our data: 2,500 subscribers.
- How often is The Kable published?
- The Kable sends on a weekly cadence according to our listing (about every 7 days).
- What should I sponsor in The Kable?
- Products that resonate with Life Sciences, Pharma, Healthcare, Technology readers tend to work best — for example Developer tools and infrastructure, Technical SaaS products, API and platform services. Use the sponsor fit section on this page to compare before you book.
- How do I book a sponsorship in The Kable?
- We do not have a verified publisher homepage for The Kable yet. Use any sponsor contact listed on this page, or browse similar newsletters in the directory while we refresh the listing.